| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 70.07× | 70.07× | 73.57× | 66.70× | 63.84× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.64× | 3.64× | 4.81× | 3.77× | 3.61× | ||
| 0.97× | 0.97× | 0.99× | 1.12× | 1.29× | ||
| 1.28× | 1.28× | 1.02× | 1.21× | 1.03× | ||
| 0.91× | 0.91× | 0.76× | 0.85× | 0.78× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 63.84 | 66.70 | 73.57 | 70.07 | 70.07 | |
| Working Capital Turnover | 3.61 | 3.77 | 4.81 | 3.64 | 3.64 | |
| Asset Turnover | 1.29 | 1.12 | 0.99 | 0.97 | 0.97 | |
| Cash Conversion (CFO/Net Income) | 1.03 | 1.21 | 1.02 | 1.28 | 1.28 | |
| CFO/EBITDA | 0.78 | 0.85 | 0.76 | 0.91 | 0.91 |